Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Phone-Based Genetic Counseling Supports Healthy Genome Sequencing
From - Diagnostic Testing & Emerging Technologies
Also at the ACMG meeting, researchers from Illumina (San Diego, Calif.) reported on a pilot project conducted at the San Diego Blood Bank where…
Getting a new lab space? Design it for safety now and save thousands later
By Dan Scungio, MT (ASCP), SLS, CQA (ASQ) bio
Let me tell you a story. Once upon a time, there was a laboratory manager who worked in a hospital that was designing a new stand-alone emergency department building which would include a…
5 ways to end generational stereotyping in your lab
By Dr. William A. Schiemann bio
These days, the Millennial Generation is hyped, perhaps even more than Baby Boomers were hyped in the 1950s and 1960s. As I meet with executives around the globe, there is widespread confusion and…
Genome Medical Bridges Genomic Testing, Medical Practice
...
Already a member? Log in here
Testing Guidelines at a Glance
...
Already a member? Log in here
Showing Test Prices May Not Change Ordering Behavior
...
Already a member? Log in here
Testosterone Testing Rises with DTC Ads
From - Diagnostic Testing & Emerging Technologies
Televised direct-to-consumer advertising (DTCA) is associated with greater testosterone testing, according to a study published March 21 in the Journal of the American Medical Association…
Biomarkers Personalize PSA Screening
From - Diagnostic Testing & Emerging Technologies
Early diagnosis of prostate cancer (PCa) is marred by a lack of consensus on the best screening strategy. Prostate specific antigen (PSA) had been…
iSpecimen Generates New Market for Discarded Biospecimens
From - Diagnostic Testing & Emerging Technologies
iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built…
Do No Harm: Diagnostic Errors and the Lab
By Jennifer (McMahon) Dawson, MHA, DLM (ASCP) bio
"Do no harm" is the mantra that health care providers live by. Doctors, nurses and laboratory professionals alike enter into the business of health care because they are motivated to…
